| Application no. and date | 13828822.0 (espacenet) (Federated) (European Patent Register), 20131213 | | Patent/reg. no. and date | DK/EP 2935299, 20191002 | | Publication date | 20151028 | | Priority no. and date | US 201261740311 P, 20121220 | | EP pub. no. and date |
EP 2935299 20151028 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81904212DK00E | | Inventor | HAN, Mingming, 2302 Old Towne Road
Nazareth, Pennsylvania 18064, US,
KAINTHAN, Rajesh Kumar, 15 Key Place
Tappan, New York 10983, US,
KIM, Jin-Hwan, 44 Somerset Drive
Suffern, New York 10901, US,
PRASAD, Avvari Krishna, 105 Worsham Drive
Chapel Hill, North Carolina 27516, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/09 (2006.01) , C07H 3/06 (2006.01) , C07K 1/107 (2006.01) | | Title | Glycokonjugationsfremgangsmåde | | Int. application no. | IB2013060933 | | Int. publication no. | WO2014097099 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
